| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a22e07ca1f2ff37f7e2ff3e596ce0d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae848ca5f6d52569b97d3cb1607b0e57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56c87f632f1262fc0b7f46a8d4c835e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_118776bdfdb9ed24170db1f30661daa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cabb29369bfab86360e6d518d1172e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c5beada7373c31322a93f74adf2345c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 |
| filingDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12248e5147f9902a4950c61df1ae8459
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad3c2966da4e81c154d92184f0825f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd08064cce73320b63a0c1ab5773487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e09beebc01fa41b2686a78d428ea786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571457de7125d49c06f5ec7b74843eaf |
| publicationDate |
2012-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012097155-A1 |
| titleOfInvention |
Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
| abstract |
The pharmaceutical compositions described comprise a therapeutically effective amount of a ferric compound and at least one bioavailability enhancer for oral delivery. Some pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a ferric compound and at least one bioavailability enhancer (e.g. a salt of a medium chain fatty acid) and a lipophilic medium. The pharmaceutical compositions may be enteric-coated. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. The methods of treatment described herein increase the level of iron in the bloodstream of a subject by administering to the subject an effective amount of an oral composition of a ferric iron compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2579868-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019513149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9402864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2579868-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560339-B2 |
| priorityDate |
2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |